Viracta Therapeutics
VIRX
#10342
Rank
NZ$1.35 M
Marketcap
$0.03406
Share price
-7.73%
Change (1 day)
-97.53%
Change (1 year)

Earnings for Viracta Therapeutics (VIRX)

Earnings in 2024 (TTM): -NZ$69.85 Million

According to Viracta Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -NZ$85.67 Million a decrease over its 2022 earnings that were of -NZ$82.54 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Viracta Therapeutics from 2020 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$69.85 Million-18.47%
2023 -NZ$85.67 Million3.78%
2022 -NZ$82.54 Million-57.13%
2021 -NZ$0.2 Billion503.47%
2020 -NZ$31.91 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.24 Billion 230.10%๐Ÿ‡บ๐Ÿ‡ธ USA